Walgreens announced last week that it would close 160 of its VillageMD clinics after it recorded a nearly $6 billion non-cash impairment charge in the second quarter, the company said. >> Read ...
Walgreens (NASDAQ:WBA) saw its stock rise 5% on Monday, May 13, following the reports that it has contacted potential buyers ...
Walgreens stock (NYSE: WBA) currently trades at $17 per share, about 70% below the level seen in April 2021, and it appears ...
Walgreens said Wednesday it is lowering prices for the summer and beyond on 1,300 items, including snacks and feminine products, joining Michaels, Target and other retailers looking to cater to ...
Walgreens is joining other retailers in cutting prices across the board, from snacks to toiletries and even Squishmallows, in an effort to lure back inflation-weary shoppers turned off by high prices.
Walgreens is lowering prices on over 1,300 products across different categories as part of a summer savings promotion, the company announced Wednesday. The company also plans to introduce a ...
May 15 (Reuters) - U.S. pharmacy chain operator Walgreens Boots Alliance (WBA.O) , opens new tab said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which ...
Unlike Walgreens, Pfizer recently raised its dividend payout for the 15th year in a row. At recent prices, it offers a 5.8% ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...
Walgreens is set to offer a cheaper version of an important opioid reversal drug at its stores soon, according to Wednesday press release. “Walgreens today announced it is expanding access to an ...
Walgreens said its generic version of Narcan will be priced at $34.99. Walgreens Boots Alliance announced Wednesday that it plans to sell its own generic version of the overdose reversal drug Narcan.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.